Prognostic Relevance of High-sensitivity Troponin in Patients With Acute Decompensated Heart Failure
The purpose of this study is to investigate the prognostic value of admission high-sensitivity troponin in patients with acute decompensated heart failure.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Prognostic Relevance of High-sensitivity Troponin in Patients With Acute Decompensated Heart Failure|
- Time to cardiovascular death or hospitalization [ Time Frame: 6 Months Follow-Up ] [ Designated as safety issue: No ]
- Time to all cause death or hospitalization [ Time Frame: 6 Months Follow-Up ] [ Designated as safety issue: No ]
|Study Start Date:||June 2010|
|Study Completion Date:||January 2012|
|Primary Completion Date:||January 2012 (Final data collection date for primary outcome measure)|
Patients admitted for acute decompensated heart failure are included in the study. After gaining informed consent, concentrations of high-sensitivity troponin on admission and on discharge are assessed. 6 months after discharged, the incidence of clinical endpoint (mortality of all cause and of cardiovascular cause, hospitalization) is assessed by telephone contact to the patient and/or the physician. The aim of the study is to investigate the prognostic value of high-sensitivity troponin concentration for predicting death and re-hospitalization.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01429857
|Innere Medizin III - Kardiologie, Angiologie und Internistische Intensivtherapie|
|Homburg, Saarland, Germany, 66421|